Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Katzenellenbogen

Showing results (181-190 of 277) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosisSpencer M Moore, Anna J Khalaj, Shalini Kumar, et al.
Journal of Cellular Physiology|February 19, 2017
Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanismsAnthony Martin, Jiali Yu, Jian Xiong, et al.
Nuclear Medicine and Biology|July 4, 2012
Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance targetJae Hak Lee, Olaf Peters, Lutz Lehmann, et al.
Breast Cancer Research and Treatment|February 27, 2023
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugsValeria Sanabria Guillen, Yvonne Ziegler, Chirag Gopinath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dioneFarrokh Dehdashti, Richard Laforest, Feng Gao, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
European Journal of Medicinal Chemistry|April 13, 2011
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximesSimone Bertini, Andrea De Cupertinis, Carlotta Granchi, et al.
Scientific Reports|January 26, 2019
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosisHawra Karim, Sung Hoon Kim, Kelli Lauderdale, et al.
Organic & Biomolecular Chemistry|October 4, 2012
Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamidesManghong Zhu, Chen Zhang, Jerome C Nwachukwu, et al.
Pageof 28

Showing results (181-190 of 277) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosisSpencer M Moore, Anna J Khalaj, Shalini Kumar, et al.
Journal of Cellular Physiology|February 19, 2017
Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanismsAnthony Martin, Jiali Yu, Jian Xiong, et al.
Nuclear Medicine and Biology|July 4, 2012
Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance targetJae Hak Lee, Olaf Peters, Lutz Lehmann, et al.
Breast Cancer Research and Treatment|February 27, 2023
Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugsValeria Sanabria Guillen, Yvonne Ziegler, Chirag Gopinath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dioneFarrokh Dehdashti, Richard Laforest, Feng Gao, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
European Journal of Medicinal Chemistry|April 13, 2011
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximesSimone Bertini, Andrea De Cupertinis, Carlotta Granchi, et al.
Scientific Reports|January 26, 2019
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosisHawra Karim, Sung Hoon Kim, Kelli Lauderdale, et al.
Organic & Biomolecular Chemistry|October 4, 2012
Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamidesManghong Zhu, Chen Zhang, Jerome C Nwachukwu, et al.
Pageof 28